Pharmaceutical Manufacturing and Formulation

The contract involves the production of Azithromycin tablets that comply with FDA current Good Manufacturing Practices (cGMP) as well as military pharmaceutical standards, ensuring high-quality manufacturing suitable for defense use. The scope covers all aspects of pharmaceutical production including active pharmaceutical ingredient (API) sourcing, formulation development, rigorous quality control measures, and batch testing to meet specified performance and safety criteria. The contract is a subcontract under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. This effort is commissioned by the Department of Defense through the Medical Supply Chain Pharmaceutical FSA and will be executed at Fort Stewart, identified by the postal code 31314-5185. The solicitation was posted on May 19, 2026, with responses due by May 22, 2026, indicating a tight deadline for proposal submissions. The contract underscores the need for adherence to stringent regulatory and military standards, reflecting the critical nature of the pharmaceutical supply chain for military operations.